Literature DB >> 6323320

Ceftizoxime (FK 749) in vitro antibacterial activity.

M O Husson, R Courcol, D Izard, H Leclerc.   

Abstract

The minimal inhibitory concentrations of ceftizoxime, cefotaxime, moxalactam, cefoperazone, cefotiam and cefamandole were determined against various species of gram-negative bacteria and against Staphylococcus aureus. Ceftizoxime was more active against Enterobacteriaceae than cefamandole, cefotiam and cefoperazone and slightly more active than or similar to moxalactam and cefotaxime. Like cefotaxime and moxalactam, ceftizoxime was less active than cefoperazone against Pseudomonas aeruginosa and less active than cefamandole against S. aureus. Ceftizoxime was active against cephalosporinase-producing Enterobacteriaceae with a mean MIC of 0.19 mg/l. However, some isolates had an MIC above 32 mg/l.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323320     DOI: 10.1007/bf01641024

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

2.  Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.

Authors:  C Thornsberry; C N Baker; L A Kirven; J M Swenson
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.

Authors:  H Kojo; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

5.  Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.

Authors:  M Nishida; T Kamimura; N Okada; Y Matsumoto; Y Mine; T Murakawa; S Goto; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1979-12       Impact factor: 2.649

6.  Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.

Authors:  D Greenwood; N Pearson; A Eley; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Comparative activities of 13 beta-lactam antibiotics.

Authors:  H L Muytjens; J van der Ros-van de Repe
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin.

Authors:  T Kamimura; Y Matsumoto; Y Shigi; M Nishida
Journal:  Arzneimittelforschung       Date:  1980

9.  Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  T Kamimura; Y Matsumoto; N Okada; Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  9 in total
  1 in total

Review 1.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.